News
-
-
PRESS RELEASE
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to 500,000 shares
CompuGroup Medical SE & Co. KGaA initiates share buy-back program for up to 500,000 shares, aiming at 0.93% of the share capital, with a maximum purchase price of EUR 15,500,000 -
-
-
-
-
PRESS RELEASE
EQS-Adhoc: General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase
CompuGroup Medical SE & Co. KGaA plans to increase dividends for 2023, proposing EUR 1.00 per share compared to EUR 0.50 in 2022. The Supervisory Board will review after finalizing financial statements -
-
PRESS RELEASE
CGM drives digitization in the healthcare sector and significantly increases revenues and operating profit margin
CompuGroup Medical SE & Co. KGaA (CGM) reports 5% increase in group revenues to EUR 1.19 billion in 2023, driven by digitization in healthcare. Adjusted EBITDA rises 13% to EUR 265 million with a 1.6 percentage point margin improvement -
PRESS RELEASE
E-prescriptions new standard in Germany: CGM with positive interim assessment
CompuGroup Medical (CGM) reports a positive interim assessment on the introduction of e-prescriptions as the new standard in German ambulatory healthcare, with around 12 million e-prescriptions issued in the first four weeks of the year
